Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DEXMEDETOMIDINE INJECTION safely and effectively. See full prescribing information for DEXMEDETOMIDINE INJECTION. DEXMEDETOMIDINE injection, for intravenous use Initial U.S. Approval: 1999
Medication labelWhy this: Advisory · dailymed-prescription
Dexmedetomidine Injection is indicated for sedation of initially intubated and mechanically ventilated adult patients during treatment in an intensive care setting. Dexmedetomidine Injection should be administered by continuous infusion not to exceed 24 hours. Dexmedetomidine Injection has been continuously infused in mechanically ventilated adult patients prior to extubation, during extubation, and post-extubation. It is not necessary to discontinue Dexmedetomidine Injection prior to extubation. Dexmedetomidine Injection is indicated for sedation of non-intubated adult patients prior to and/or during surgical and other procedures. Pediatric use information is approved for Hospira, Inc.'s PRECEDEX™ (dexmedetomidine hydrochloride injection). However, due to Hospira, Inc.'s marketing exclusivity rights, this drug product is not labeled with that information.
- generic_name
- dexmedetomidine
- product_names
- dexmedetomidine
- ndc
- 83634-600, 83634-600-41, 83634-600-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en